Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 4, 2013, Pages 416-424

  Seyhan, Ekrem Cengiz ^a   Özgül, Mehmet Akif ^a   Tutar, Nuri ^b   Ömür, Imran ^c   Uysal, Atilla ^a   Altin, Sedat ^a  

^a Yedikule Teaching Hospital   (Turkey)

^b Department of Chest Diseases   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Mortality; Red blood cell distribution; Stable COPD

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CARBON DIOXIDE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CARBON DIOXIDE TENSION; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE PARAMETERS; FEMALE; FORCED EXPIRATORY VOLUME; HEART RIGHT VENTRICLE FAILURE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RED BLOOD CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY;

AGED; C-REACTIVE PROTEIN; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE INDICES; ERYTHROCYTES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84880755575     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.758697     Document Type: Article

References (42)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-1442.
2. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12(5):634-641.
3. Agustí A. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367-370.
4. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991: 9:71-74.
5. Romero AJ, Carbia CD, Ceballo MF, Diaz NB. Red cell distribution width (RDW): its use in the characterization of microcytic and hypochromic anemias. Medicina (B Aires) 1999; 59:17-22.
6. Williams WJ. Examination of the blood. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology, 3rd ed. New York: McGraw-Hill, 1983: 9-14.
7. Seppa K, Sillanaukee P, Saarni M. Blood count and hematologic morphology in nonanemic macrocytosis: differences between alcohol abuse and pernicious anemia. Alcohol 1993; 10:343-347.
8. Pierce CN, Larson DF. Infl ammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory asist device. Perfusion 2005; 20:83-90.
9. Ozkalemkas F, Ali R, Ozkocaman V, Ozan U, Oztürk H, Kurt E, Evrensel T, Yerici O, Tunali A. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer 2005; 5:144.
10. Anderson JL, Ronnow BS, Horne BD, Carlquist JF, May HT, Bair TL, Jensen KR, Muhlestein JB. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol 2007; 99:169-174.
11. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50:40-47.
12. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008; 117:163-168.
13. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution widih and the risk of death in middle-aged and older adults. Arch lntern Med 2009; 169:515-523.
14. Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch lntern Med 2009; 169:588-594.
15. Oudijk EJ, Lammers JW, Koenderman L. Systemic infl ammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 22:5-13.
16. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004; 59:574-580.
17. Palange P, Testa U, Huertas A, Calabrò L, Antonucci R, Petrucci E, Pelosi E, Pasquini L, Satta A, Morici G, Vignola MA, Bonsignore MR. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006; 27:529-541.
18. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of infl ammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51:819-824.
19. Borne Y, Smith JG, Melander O, Hedblad B, Engstrom G. Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail 2011; 13:1355-1361.
20. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK, Lenihan DJ, Oren RM, Wagoner LE, Schwartz TA, Adams KF Jr. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail 2010;16: 230-238.
21. Van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi Jr JL. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010; 12:129-136.
22. Lappe JM, Horne BD, Shah SH, May HT, Muhlestein JB, Lappé DL, Kfoury AG, Carlquist JF, Budge D, Alharethi R, Bair TL, Kraus WE, Anderson JL. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population. Clin Chim Acta 2011; 412:2094-2099.
23. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009; 104:868-872.
24. Zorlu A, Bektasoglu G, Guven FM, Gucuk E, Ege MF, Altay H, Cinar Z, Tandogan I, Yilmaz MB. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol 2012; 109:128-134.
25. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010; 105: 312-317.
26. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
27. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group. Geneva: World Health Organization, 2009.
28. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1298.
29. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5:133-138.
30. Semba RD, Patel KV, Ferrucci L, Sun K, Roy CN, Guralnik JM, Fried LP (2010) Serum antioxidants and infl ammation predict red cell distribution width in older women: The Women's Health and Aging Study I. Clin Nutr 29: 600-604.
31. Garcez ME, Peres W, Salvador M. Oxidative stress and hematologic and biochemical parameters in individuals with Down syndrome. Mayo Clin Proc 2005; 80:1607-1611.
32. Grant BJ, Kudalkar DP, Muti B McCann SE, Trevisan M, Freudenheim JI, et al. Relation between lung function and RBC distribution width in a population-based study. Chest 2003; 124(2):494-500.
33. Kobayashi S, Moriya H, Aso K, Ohtake T. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 2003; 63:1881-1887.
34. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:369-373.
35. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in COPD. Am J Respir Crit Care Med 2007; 175:250-255.
36. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and infl ammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 2009; 133:628-632.
37. Fukuta H, ohte N, Mukai S, Saeki T, Asada K, Wakami K, Kimura G. Elevated plasma levels of B-type natriuretic Peptide but not c-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J 2009; 50:301-312.
38. Chambellan A, Chailleux E, Similowski T, and the ANTADIR observatory group. Prognostic value of the hematocrit in patients with severe COPD receiving longterm oxygen therapy. Chest 2005; 128:1201-1208.
39. Spell DW, Jones J, Harper WF, Bessman DJ. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prevent 2004; 28:37-42.
40. Klinger JR, Hill NS. Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management. Chest 1991 Mar; 99(3):715-723.
41. Sincer I, Zorlu A, Yilmaz MB, Dogan OT, Ege MR, Amioglu G, Aydin G, Ardic I, Tandogan I. Relationship between red cell distribution width and right ventricular dysfunction in patients with chronic obstructive pulmonary disease. Heart Lung 2012 May; 41(3):238-243.
42. Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, et al. Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010; 188:321-329.